Gelsolin recombinant actin-severing protein: Phase I trial in the U.K.

Biogen Inc. (BGEN), Cambridge, Mass.
Product: Gelsolin

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE